Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Country / region: Poland Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20123
20141
20152
20164
20171
20182
20193
20201
20211
20223
20233
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting7
Terminated7
Active, not recruiting4
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Janssen Research & Development, LLC3
AstraZeneca2
BioNTech SE2
Pfizer2
AbbVie1
BerGenBio ASA1
BioAtla, Inc.1
Clovis Oncology, Inc.1
Galecto Biotech AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung31
Melanoma8
Triple Negative Breast Neoplasms6
Squamous Cell Carcinoma of Head and Neck4
Stomach Neoplasms4
Carcinoma, Renal Cell3
Neoplasm Metastasis3
Neoplasms3
Carcinoma2
Colorectal Neoplasms2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.